CT83 and cancer: We found KK-LC-1 was enriched in the “Pathway in Cancer”, “Breast Cancer Pathway”, “Mammary Gland Epithelium Development”, “Wnt Beta-catenin Pathway”, “PI3K/AKT Signaling Pathway, “and “AKT, mTOR” (Additional file 8D–I).